Premium
The missing middle of sickle therapeutics: Multi‐agent therapy, targeting risk, using biomarkers
Author(s) -
Hebbel Robert P.,
Elion Jacques,
Kutlar Abdullah
Publication year - 2018
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25289
Subject(s) - medicine , intensive care medicine , oncology
Division of Hematology-Oncology-Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota UMR_S1134, Inserm, Université Paris Diderot, Sorbonne Paris Cité; Institut National de la Transfusion Sanguine, Laboratoire d'Excellence GR-Ex, Paris, France Division of Hematology/Oncology, Department of Medicine, Augusta University, Augusta, Georgia Correspondence Robert P. Hebbel, MMC 480, 420 Delaware St. S.E., Minneapolis, MN 55455. Email: hebbe001@umn.edu